| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 43.329 | 46.733 | 45.457 | 44.788 | 77.107 | 95.004 | 76.159 | 141.719 | 137.231 |
| Total Income - EUR | - | 43.377 | 47.285 | 45.605 | 45.085 | 77.347 | 95.192 | 76.247 | 141.729 | 138.550 |
| Total Expenses - EUR | - | 6.267 | 21.560 | 16.226 | 11.850 | 10.064 | 17.803 | 31.144 | 49.135 | 59.507 |
| Gross Profit/Loss - EUR | - | 37.110 | 25.724 | 29.378 | 33.236 | 67.283 | 77.389 | 45.103 | 92.594 | 79.042 |
| Net Profit/Loss - EUR | - | 35.809 | 24.311 | 28.109 | 31.978 | 65.430 | 74.989 | 43.581 | 91.313 | 75.194 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medstud Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 706 | 2.810 | 1.627 | 1.684 | 2.066 | 37.149 | 30.325 | 25.175 | 19.571 |
| Current Assets | - | 37.114 | 26.307 | 27.351 | 32.076 | 64.708 | 40.216 | 51.949 | 69.134 | 117.627 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 5.791 | 0 | 0 |
| Receivables | - | 6.851 | 1.860 | 1.733 | 853 | 8.593 | 953 | 36.393 | 23.608 | 75.414 |
| Cash | - | 30.263 | 24.448 | 25.618 | 31.223 | 56.115 | 39.263 | 9.765 | 45.526 | 42.213 |
| Shareholders Funds | - | 35.854 | 24.355 | 28.152 | 32.509 | 65.471 | 75.038 | 43.630 | 91.361 | 75.243 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.966 | 4.762 | 827 | 1.252 | 1.303 | 2.327 | 38.645 | 2.948 | 61.956 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medstud Srl